Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free
BNF presentation 0501013K0AAAGAG within chapter Infections. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0501013K0AAAGAG
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
20,212
NHS spend (£)
£100,438.95
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 2,118 |
| February 2025 | 22 |
| December 2024 | 674 |
| November 2024 | 2,777 |
| October 2024 | 3,057 |
| September 2024 | 22 |
| August 2024 | 198 |
| July 2024 | 3,278 |
| May 2024 | 840 |
| July 2021 | 1,159 |
| June 2021 | 789 |
| December 2020 | 2,395 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 59 | No data available |
|
Beacon Medical Group
ODS L83100
|
41 | 15N - DEVON ICB |
| Unknown pharmacy | 38 | No data available |
| Unknown pharmacy | 34 | No data available |
| Unknown pharmacy | 33 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 32 | No data available |
| Unknown pharmacy | 29 | No data available |
| Unknown pharmacy | 29 | No data available |
| Unknown pharmacy | 29 | No data available |